CG Oncology(CGON) - 2024 Q1 - Quarterly Results

Date of report (Date of earliest event reported) May 9, 2024 CG Oncology, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (Exact Name of Registrant as Specified in Charter) Delaware 001-41925 37-1611499 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 400 Spectrum Center Drive, Suite 2040 Irvine, CA 92618 (949) 409-3700 (Address an ...